Results 71 to 80 of about 4,236 (180)

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +2 more sources

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VI: Accreditation process. [PDF]

Hematol Transfus Cell Ther, 2021
De Santis GC, Ubiali EMA, Zanelli APRD, Mendrone Junior A, Feitoza A, Kutner JM, Orellana MD, Rizzo SRCP, Covas DT, Langhi Junior DM.   +9 more
europepmc   +1 more source

New methodologies for old problems: tridimensional gastrointestinal organoids and guts-on-a-chip

Journal of Coloproctology, 2018
Objectives: The present review intended to present a critical overview of the methodological and experimental advances concerning tridimensional cell culture models within the scope of gastrointestinal research. Methods: A literature review was performed
Marna Eliana Sakalem, João Tadeu Ribeiro-Paes   +1 more
doaj   +1 more source

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. V: Manufacture and quality control. [PDF]

Hematol Transfus Cell Ther, 2021
De Santis GC, Langhi Junior DM, Feitoza A, Mendrone Junior A, Kutner JM, Covas DT, Couto SCF, Guerino-Cunha RL, Orellana MD, Rizzo SRCP.   +9 more
europepmc   +1 more source

Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I. [PDF]

Hematol Transfus Cell Ther, 2022
Maiolino A, Crusoé EQ, Martinez GA, Braga WMT, de Farias DLC, Bittencourt RI, Neto JVP, Ribeiro GN, Bernardo WM, Tristão L, Magalhaes RJP, Hungria VTM.   +11 more
europepmc   +1 more source

Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumors. [PDF]

Hematol Transfus Cell Ther, 2021
Nardo M, Motta TC, Colli LM, Avanzi MP.
europepmc   +1 more source

Terapia Celular: células CAR-T

, 2021
Therapy with CAR-T cells consists of the genetic modification of autologous T cells to express on their surface a chimeric antigenic receptor that will be directed to a target antigen, resulting in the elimination of the tumor due to the cytotoxic activity of the T cells. Currently, there are more than 500 clinical trials underway in the world in which
openaire   +1 more source

Liver Fibrosis and Protection Mechanisms Action of Medicinal Plants Targeting Apoptosis of Hepatocytes and Hepatic Stellate Cells

Advances in Pharmacological Sciences, 2014
Following chronic liver injury, hepatocytes undergo apoptosis leading to activation of hepatic stellate cells (HSC). Consequently, activated HSC proliferate and produce excessive extracellular matrix, responsible for the scar formation.
Florent Duval, Jorge E. Moreno-Cuevas, Maria Teresa González-Garza, Carlos Rodríguez-Montalvo, Delia Elva Cruz-Vega   +4 more
doaj   +1 more source

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients. [PDF]

Hematol Transfus Cell Ther, 2021
Maiolino A, Costa LJ, Pasquini M, Crusoe EQ, Vigorito AC, Salvino MA, Seguro FS, Filho JS, Hungria VTM.   +8 more
europepmc   +1 more source

Terapia Celular con Células Madre

, 2009
Terapia Celular con Células Madre. Colegio Nacional de Médicos Militares 2009; 1, 24-25 En el ámbito de la nueva medicina regenerativa y antienvejecimiento, la terapia celular emplea células madre con el propósito de restaurar lo perdido o dañado en las células envejecidas, así como también en los tejidos enfermos del organismo, utilizando innovadoras
openaire   +1 more source